<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Thanh Le</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Andreadakis</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gomez Roman</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tollefsen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Saville</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>The COVID-19 vaccine development landscape.</article-title>
  <source>
   <italic>Nat. Rev. Drug Discov.</italic>
  </source>
  <volume>19</volume>
  <fpage>305</fpage>â€“
  <lpage>306</lpage>.
  <pub-id pub-id-type="pmid">32273591</pub-id>
 </mixed-citation>
</ref>
